Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	7.66B
Revenue (ttm)	3.78B -5.3%
Net Income	214.11M -9.5%
EPS	0.21 -12.0%
Shares Out	1.02B
PE Ratio	35.88
Forward PE	27.25
Dividend	0.12 (1.59%)
Ex-Dividend Date	n/a

Volume	11,643,783
Average Volume	11,705,868
Open	7.52
Previous Close	7.54
Day's Range	7.42 - 7.60
52-Week Range	6.70 - 9.42
Beta	1.57
RSI	47.87
Earnings Date	Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It provides cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. Further, it serves hospitals, pharmacies, primary medical institutions, and chain drug stores, etc. The company was for...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,630
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2024, SHA:600223's revenue was 3.98 billion, a decrease of -13.02% compared to the previous year's 4.58 billion. Earnings were 243.53 million, a decrease of -19.73%.